HOME > ARCHIVE
ARCHIVE
- Pharmacies Entertain Hope of Generic Substitution
May 20, 2002
- Sanko Junyaku, Tokai Univ. to Codevelop Reagents Using PALSAR
May 20, 2002
- JMARI Urged Gov't to Promote Proper Use of Antibiotics via Payment Incentives
May 20, 2002
- Denka Seiken: Influenza Vaccines Increase Sales by 19%
May 20, 2002
- On-line Medical Billing Studied by Korosho Group
May 20, 2002
- Denka Seiken Obtains FDA Approval for MRSA Detection Reagent
May 20, 2002
- GL on Treatment of Cerebral Infarctions
May 20, 2002
- Building Trust with Drs Is Important: Mr Bootes of Pfizer
May 20, 2002
- Draft RA Care Guidelines Presented: JRA
May 20, 2002
- JHSF Urges Makers to Beef Up Int'l Competitiveness in Genomic Drug Discovery
May 20, 2002
- WORLD NEWS IN BRIEF
May 20, 2002
- Trends in Informatics Reported by JHSF
May 20, 2002
- R&D Synergy to Accelerate Antibody Therapeutics: Chugai, Roche
May 20, 2002
- Increases in CAM-Resistant Hp Require Alternative Regimens
May 20, 2002
- Kumakura to Follow Path of His Predecessor: Kuraya Sanseido
May 20, 2002
- Epidural PCA Effective for Postoperative Pain
May 20, 2002
- GL Covering All Clinical Research to Be Drafted
May 13, 2002
- Daiichi Starts Research on Thrombosis Genes with Keio Univ.
May 13, 2002
- Monkasho Drafts GL on Intellectual Property Rights
May 13, 2002
- Sysmex Joins Hands with Keio Univ. for Advanced Medicine Project
May 13, 2002
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
